Brazil’s Senate rejected President Luiz Inácio Lula da Silva’s nominee for the Supreme Court, a direct setback for his administration ahead of the 2026 presidential election. The market for Tarcísio de Freitas winning the 2026 Brazilian presidential race has not yet updated with new odds.
Market reaction
The market for Tarcísio de Freitas’ potential victory is currently inactive, with no significant volume or price moves recorded. Traders appear to still be processing the implications of the Senate vote. The rejection weakens Lula’s hand in shaping the judiciary, which in Brazilian politics frequently decides major constitutional and policy disputes.
Why it matters
The failed nomination exposes cracks in Lula’s Senate coalition with the October 2026 election approaching. The Supreme Court in Brazil rules on everything from electoral disputes to economic policy, so losing a seat appointment is not just symbolic. If Lula cannot hold his coalition together on judicial nominations, his ability to pass legislation and project strength as a candidate comes into question. Opposition figures like Tarcísio de Freitas benefit directly from that perception of weakness.
What to watch
A potential 15% movement in Tarcísio de Freitas’ odds would represent a meaningful recalibration for traders. Key signals to monitor: whether Lula attempts another nominee and how the Senate responds, polling data showing any shift in public sentiment toward opposition candidates, and any legislative maneuvers by Lula’s coalition to recover momentum. Further Senate defeats would compound the damage to Lula’s electoral positioning.
API CTA
Get prediction market intelligence as a structured API feed. Early access waitlist.
Term Structure| Contract | Odds | Δ since publish | Volume 24h | |
|---|---|---|---|---|
| June 30 | 37.5% | — | — | View market → |
| December 31 | 63.5% | — | — | View market → |
| April 30 | 1.4% | — | — | View market → |
| May 31 | 23.5% | — | — | View market → |
Gloria API — Event-driven market intelligence, structured for analysis.
Join the Waitlist
